IPSC · ISSUER CIK 1850119
Century Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Century Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $10K of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$10KInsider selling
−$10KNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202618:25 | Sep 14, 2026 | IPSC | See Remarks | S · Sell | $1.93 | −2,587 | 509,198 | -1% | −$5K | ||
| Sep 15, 202618:25 | Sep 14, 2026 | IPSC | SVP Finance & Operations | S · Sell | $1.93 | −1,658 | 502,907 | -0% | −$3K | ||
| Sep 15, 202618:23 | Sep 11, 2026 | IPSC | President and CEO, Director | F · Tax | $1.94 | −13,850 | 3,633,839 | -0% | $27K | ||
| Sep 9, 202616:36 | Sep 4, 2026 | IPSC | President and CEO, Director | F · TaxLate 5d | $2.11 | −463 | 3,633,839 | -0% | $976.93 | ||
| Sep 9, 202616:35 | Sep 8, 2026 | IPSC | See Remarks | S · Sell | $2.05 | −534 | 511,785 | -0% | −$1K | ||
| Sep 9, 202616:34 | Sep 8, 2026 | IPSC | SVP Finance & Operations | S · Sell | $2.05 | −254 | 504,565 | -0% | −$520.70 | ||
| Aug 18, 202616:17 | Aug 14, 2026 | IPSC | President and CEO, Director | F · Tax | $1.92 | −31,172 | 3,634,302 | -1% | $60K | ||
| Aug 5, 202616:08 | Aug 3, 2026 | IPSC | SVP Finance & Operations | S · Sell | $1.98 | −275 | 504,819 | -0% | −$543.68 |